NPIP Webinar Series
Revolutionising Imaging: The Power and Promise of LAFOV PET and the NPIP Network
Welcome to the NPIP Webinar Hub – you can find details of upcoming webinars featuring experts from the field of PET (Positron Emission Tomography), who will share their perspectives and insights.
NPIP is the UK’s first national total-body PET imaging platform dedicated to accelerating drug discovery research. This groundbreaking initiative is paving the way for scientific advances that will shape how we predict, diagnose, and treat disease, now and for decades to come.
By bringing the nation’s clinical PET imaging research into one connected platform, NPIP is opening new possibilities for clinicians, researchers, and patients alike. Its impact will be felt across medical and academic communities through deeper insights, faster discovery, and a clearer understanding of disease at the molecular level.
This multi-part webinar series will explore the transformative potential of Long Axial Field-of-View (LAFOV) PET systems. Through a curated sequence of talks by global experts, the series will discuss how these systems are redefining imaging in clinical research, drug discovery, and clinical diagnostics. A dedicated session will also delve into the vision of NPIP to enable collaborative and scalable research.
Register now
Upcoming Webinars
We are planning an initial six sessions in the NPIP webinar series. Following each event, recordings and slides will be made available on this page. Bookmark this hub to revisit sessions, share key insights with colleagues, or explore content you may have missed. Information on the first session is below:
Webinar 2: LAFOV PET Imaging: Redefining the Future of Women’s Health
Date: 29 January 2026, 4 pm (GMT)
Register now
Speakers
- Dr Thomas Wagner, Royal Free London NHS Trust
- Dr Beverley Holman, Royal Free London NHS Trust
- Dr Lucy H R Whitaker, Centre for Reproductive Health, Institute for Regeneration and Repair, Edinburgh BioQuarter
About this webinar
Discover how Long Axial Field-of-View (LAFOV) PET imaging is transforming women’s health. This cutting-edge technology delivers unprecedented image quality, faster scans, and lower radiation exposure, unlocking new possibilities for early detection, personalised treatment, and improved patient outcomes. Join us as leading experts explore the clinical advantages, research opportunities, and future implications of LAFOV PET for advancing care for women worldwide.
Webinar 2 Speakers
Dr Thomas Wagner
Consultant in Nuclear Medicine, Royal Free London NHS Trust
Dr Beverley Holman
Principal Diagnostic Nuclear Medicine, PET/CT and Research Physicist Royal Free London NHS Trust
Dr Lucy H R Whitaker
Senior Clinical Research Fellow and Honorary Consultant Gynaecologist, Centre for Reproductive Health, Institute for Regeneration and Repair, Edinburgh BioQuarter
Webinar 3: LAFOV PET Imaging: Non-invasive In Vivo Thrombus Imaging in Cardiovascular Disease
Date: 11 February 2026, 4 pm (GMT)
Register now
Speakers
- Professor David Newby, The University of Edinburgh
- Dr Dr Jason Tarkin, University of Cambridge
- Dr William Drewe, NPIP
About this webinar
The application of Long Axial Field-of-View (LAFOV) PET imaging continues with this webinar dedicated to Non-invasive In Vivo Thrombus Imaging in Cardiovascular Disease.
Webinar 3 Speakers
Professor David Newby
The University of Edinburgh
Dr Jason Tarkin
University of Cambridge
Dr William Drewe
NPIP PET Engagement and Delivery Manager
Webinar 1: Introduction to Long Axial Field of View (LAFOV) PET: Capabilities and Transformational Potential – Recorded on 12 January 2026
Speakers:
- Simon R. Cherry, University of California, Davis, and King’s College London
- Dr Antonis Kalemis, Siemens Healthineers
- Stewart Young, United Imaging
About this webinar
Unlock the next generation of PET with this essential introductory session on Long Axial Field of View (LAFOV) technology.
Traditional PET has reached new limits — LAFOV PET moves far beyond them. This session offers clinicians a clear understanding of the foundations, performance advantages, and clinical opportunities enabled by LAFOV systems.
Highlights include:
- The key differences between LAFOV and conventional PET
- Engineering breakthroughs behind modern total-body systems
- Early data showing unprecedented sensitivity, resolution, and whole-body dynamic imaging
- Adoption trends, barriers, and what they mean for future clinical practice
- Stay ahead of the curve in molecular imaging and discover what LAFOV PET could unlock for your patients